Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.

Inclusion criteria

• Sex: Both (50% women; 50% men).
• Age: 18-65 years.
• Subjects with hair loss due to telogen effluvium or mild or incipient androgenic alopecia, in an 80/20 ratio.
• Degree of androgenic alopecia: Ludwig scale score I-II for women and Hamilton-Norwood scale score III-II for men.
• Telogen effluvium: Combing test.
• Subjects with all hair types (oily, combination, sensitive, etc.).
• Subjects with all scalp types (normal, sensitive, etc.).
• Agree to participate voluntarily in the study and provide written informed consent.
• Adequate level of understanding of the clinical study.
• Good health (physical and mental).
• Availability to attend visits to the research centres.
• No application of any product to the experimental area on the first day of the trial.

Exclusion criteria

• Individuals under 18 years of age.
• Pregnant or breastfeeding women.
• Injuries or infection in the test area.
• History of allergies to cosmetic products.
• Known allergies to product components.
• Sensitivity to any product component.
• Patients who have undergone recent surgery or treatments in the study area.
• Cancer patients.
• Volunteers currently taking antibiotics, antihistamines, corticosteroids, beta-blockers, retinoids, azelaic acid, or acne therapies, or whose treatment ended within 15 days prior to the start of the study. Participation in another clinical study.
• Use of or having used cosmetic products and/or oral or topical treatments for hair loss for at least 6 months.
• Hair cutting or dyeing during the study.
• Health problems, to be assessed by the specialist, that may compromise adherence to the study protocol.